Indicator,S.No.,Parameters,Type,District - _Delhi,District - Central,District - East,District - New Delhi,District - North,District - North East,District - North West,District - Shahdara,District - South,District - South East,District - South West,District - West
M1 [Ante Natal Care Services ANC],1.1,Total number of pregnant women Registered for ANC,TOTAL,502919,60905,26467,50304,48959,27894,54217,74649,22113,29919,20713,86779
M1 [Ante Natal Care Services ANC],1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,159340,18266,7136,10367,12641,10443,20270,13939,8341,14506,9979,33452
M1 [Ante Natal Care Services ANC],1.2,Number of Pregnant women registered under JSY,TOTAL,13968,2390,536,792,1007,614,2036,1129,284,796,1075,3309
M1 [Ante Natal Care Services ANC],1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,287975,38625,12864,31770,24036,16824,41506,30716,12331,15770,14500,49033
M1 [Ante Natal Care Services ANC],1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,154340,17108,8474,13092,14079,10963,20257,17442,8343,12068,10464,22050
M1 [Ante Natal Care Services ANC],1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,136129,16172,8379,10301,13298,10162,17421,14189,7730,10938,9685,17854
M1 [Ante Natal Care Services ANC],1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,273056,25805,11353,33281,27306,14323,36117,28704,10968,11727,13854,59618
M1 [Ante Natal Care Services ANC],1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,9907,652,198,1182,561,219,1366,725,701,227,1361,2715
M1 [Ante Natal Care Services ANC],1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,742,219,6,137,34,6,88,81,16,11,11,133
M1 [Ante Natal Care Services ANC],1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,153643,17445,7604,18531,15611,9757,28241,12954,4231,9729,13232,16308
M1 [Ante Natal Care Services ANC],1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8370,398,196,883,636,170,1683,1495,177,166,1203,1363
M1 [Ante Natal Care Services ANC],1.8,Number of pregnancy test kits used at SC level,TOTAL,12516,458,501,1062,520,1006,328,708,3659,3330,221,723
M2 [Deliveries],2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,682,0,95,6,5,0,31,0,231,281,3,30
M2 [Deliveries],2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,7772,530,280,215,1666,1257,731,306,700,627,451,1009
M2 [Deliveries],2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,8454,530,375,221,1671,1257,762,306,931,908,454,1039
M2 [Deliveries],2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,4185,374,216,130,817,424,194,247,432,435,256,660
M2 [Deliveries],2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,33,6,0,11,0,1,1,0,5,2,7,0
M2 [Deliveries],2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,105482,16982,4348,21923,3806,3050,16385,17477,2764,1955,5051,11741
M2 [Deliveries],2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,48808,8766,2435,15350,1430,2377,2007,2940,1688,1169,3726,6920
M2 [Deliveries],2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,5255,860,252,427,731,71,981,414,184,127,658,550
M2 [Deliveries],2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1852,386,261,276,1,18,35,39,166,85,470,115
M2 [Deliveries],2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M2 [Deliveries],2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,21006,4332,1681,99,425,95,3605,1580,2242,2527,969,3451
M2 [Deliveries],2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,16,0,NA,16,NA,0,0,NA,NA,0,NA,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,23747,4154,818,5504,233,317,3664,4021,877,250,873,3036
M3 [Number of Caesarean C-Section deliveries performed at],3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M3 [Number of Caesarean C-Section deliveries performed at],3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,23763,4154,818,5520,233,317,3664,4021,877,250,873,3036
M3 [Number of Caesarean C-Section deliveries performed at],3.2,No. of C-section deliveries performed at Private facilities,TOTAL,12505,2638,1078,52,140,62,2347,993,1085,1311,596,2203
M4 [Pregnancy outcome & weight of new-born],4.1.1.a,Number of male live births,TOTAL,70613,11462,3329,11560,3039,2236,10848,10212,3185,2862,3450,8430
M4 [Pregnancy outcome & weight of new-born],4.1.1.b,Number of female live births,TOTAL,63168,10192,3003,10386,2822,2144,9711,8913,2781,2575,2986,7655
M4 [Pregnancy outcome & weight of new-born],4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,133781,21654,6332,21946,5861,4380,20559,19125,5966,5437,6436,16085
M4 [Pregnancy outcome & weight of new-born],4.1.2,Number of still births,TOTAL,2584,482,104,583,72,30,427,418,82,42,58,286
M4 [Pregnancy outcome & weight of new-born],4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18557,2840,1877,1486,1165,289,2640,1827,1380,1226,912,2915
M4 [Pregnancy outcome & weight of new-born],4.2.1,Number of Newborns weighed at birth,TOTAL,126574,20277,6146,20497,5398,3763,20070,19033,5687,4814,6311,14578
M4 [Pregnancy outcome & weight of new-born],4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,27509,4530,1252,3180,947,775,4573,5945,929,547,1060,3771
M4 [Pregnancy outcome & weight of new-born],4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,98493,14137,3860,17567,5143,3555,14933,15561,4482,3624,4931,10700
M5 [Complicated pregnanices],5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6,0,0,0,0,0,0,0,6,0,0,0
M5 [Complicated pregnanices],5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,351,0,6,0,10,118,20,119,NA,77,NA,1
M5 [Complicated pregnanices],5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,35205,8504,1990,4751,3300,153,3129,5970,2297,339,1086,3686
M5 [Complicated pregnanices],5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M5 [Complicated pregnanices],5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,35562,8504,1996,4751,3310,271,3149,6089,2303,416,1086,3687
M5 [Complicated pregnanices],5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,4551,781,128,0,183,54,465,702,909,910,180,239
M5 [Complicated pregnanices],5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,26384,5920,2116,2870,552,234,3082,4454,1612,1268,1054,3222
M5 [Complicated pregnanices],5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2825,276,10,452,112,129,195,604,203,83,80,681
M5 [Complicated pregnanices],5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,25268,8317,1710,2098,733,248,2883,2889,1929,1265,677,2519
M5 [Complicated pregnanices],5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,8374,799,851,1401,286,27,1368,1546,189,78,205,1624
M6 [Post - Natal Care],6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,117068,17144,5112,20898,5299,3937,18544,16668,5188,4697,6205,13376
M6 [Post - Natal Care],6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,84554,11818,3579,7553,4649,3676,11927,10498,2212,4069,8220,16353
M6 [Post - Natal Care],6.3,PNC maternal complications attended,TOTAL,3249,186,739,333,140,0,796,222,38,181,211,403
M7 [Medical Termination of Pregnancy (MTP)],7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3281,597,39,432,123,34,581,307,343,169,147,509
M7 [Medical Termination of Pregnancy (MTP)],7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,473,59,5,124,4,0,41,82,124,0,6,28
M7 [Medical Termination of Pregnancy (MTP)],7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3754,656,44,556,127,34,622,389,467,169,153,537
M7 [Medical Termination of Pregnancy (MTP)],7.2,Number of MTPs conducted at Private Facilities,TOTAL,6562,965,1251,61,182,12,961,559,410,822,337,1002
M8 [RTI/STI Cases],8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,17491,2726,849,3279,1148,698,1326,673,1289,1569,1403,2531
M8 [RTI/STI Cases],8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,90666,11128,5542,12672,5766,6552,8433,5666,3111,4782,4905,22109
M8 [RTI/STI Cases],8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,108157,13854,6391,15951,6914,7250,9759,6339,4400,6351,6308,24640
M8 [RTI/STI Cases],8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,280,0,2,0,0,0,0,0,23,19,6,230
M9 [Family Planning],9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,884,619,8,86,5,8,18,15,7,0,77,41
M9 [Family Planning],9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,884,619,8,86,5,8,18,15,7,0,77,41
M9 [Family Planning],9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,27,25,1,0,0,NA,0,0,1,0,0,0
M9 [Family Planning],9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2924,936,14,477,38,11,387,178,320,34,125,404
M9 [Family Planning],9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,2924,936,14,477,38,11,387,178,320,34,125,404
M9 [Family Planning],9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,1000,26,28,70,5,NA,507,222,11,105,2,24
M9 [Family Planning],9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,977,112,49,495,18,2,100,72,23,2,56,48
M9 [Family Planning],9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,977,112,49,495,18,2,100,72,23,2,56,48
M9 [Family Planning],9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,78,10,7,0,2,NA,14,0,17,15,0,13
M9 [Family Planning],9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,6,0,NA,6,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2306,269,0,318,19,23,665,457,85,21,65,384
M9 [Family Planning],9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2312,269,0,324,19,23,665,457,85,21,65,384
M9 [Family Planning],9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,171,38,3,0,6,NA,16,3,5,36,3,61
M9 [Family Planning],9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,8,8,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,12857,2032,865,723,768,1100,1173,736,1074,1226,1366,1794
M9 [Family Planning],9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4276,540,316,234,351,637,413,431,NA,480,77,797
M9 [Family Planning],9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,25932,4032,1438,3606,1949,688,4619,3066,999,539,887,4109
M9 [Family Planning],9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,43073,6612,2619,4563,3068,2425,6205,4233,2073,2245,2330,6700
M9 [Family Planning],9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,22505,3501,1451,2974,1637,855,3786,2651,550,521,629,3950
M9 [Family Planning],9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1942,278,130,97,132,16,307,215,118,275,93,281
M9 [Family Planning],9.06,Number of IUCD removals,TOTAL,6942,897,487,591,489,429,849,533,480,553,577,1057
M9 [Family Planning],9.07,Number of Oral Pills cycles distributed,TOTAL,101213,11246,7335,7805,9675,7177,11620,9802,6351,12041,6894,11267
M9 [Family Planning],9.08,Number of Condom pieces distributed,TOTAL,3651409,431717,131991,260932,370626,200751,597437,205938,340166,412877,285366,413608
M9 [Family Planning],9.09,Number of Centchroman (weekly) pills given,TOTAL,112,63,0,0,0,0,0,0,30,0,8,11
M9 [Family Planning],9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,7958,566,766,438,1006,677,948,574,995,658,399,931
M9 [Family Planning],9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.1.b,Number of cases of complications following female sterilization,TOTAL,11,0,0,0,0,0,0,8,0,0,2,1
M9 [Family Planning],9.11.2.a,Number of failures following male sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,1
M9 [Family Planning],9.11.2.b,Number of failures following female sterilization,TOTAL,27,8,0,4,1,0,5,6,0,0,0,3
M9 [Family Planning],9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.12,Number of Institutions having NSV trained doctors,TOTAL,322,34,23,44,19,3,75,43,28,17,13,23
M10 [CHILD IMMUNIZATION],10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,149363,19268,7899,23654,8885,6804,21808,20280,6722,8020,7456,18567
M10 [CHILD IMMUNIZATION],10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8681,1233,469,100,356,462,1341,492,874,1488,214,1652
M10 [CHILD IMMUNIZATION],10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7459,1107,440,97,302,437,939,371,784,1356,227,1399
M10 [CHILD IMMUNIZATION],10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7156,1158,417,106,280,396,936,395,614,1278,216,1360
M10 [CHILD IMMUNIZATION],10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,137639,13480,9052,7826,13291,13651,17693,12463,8196,13046,10670,18271
M10 [CHILD IMMUNIZATION],10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,137599,13036,9888,7145,13576,13514,17977,11793,8504,13253,10632,18281
M10 [CHILD IMMUNIZATION],10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,141275,13336,9742,7299,14080,13515,18564,11959,8792,13547,11227,19214
M10 [CHILD IMMUNIZATION],10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,118419,17281,6030,21210,4642,3703,17611,18207,5029,4235,5746,14725
M10 [CHILD IMMUNIZATION],10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,142738,14601,9652,7738,13401,13815,18201,12876,7579,14248,10827,19800
M10 [CHILD IMMUNIZATION],10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,142159,14118,10242,7037,13619,13757,18346,12108,8178,14331,10846,19577
M10 [CHILD IMMUNIZATION],10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,145754,14416,10241,7260,14019,13682,18755,12171,8562,14714,11447,20487
M10 [CHILD IMMUNIZATION],10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,111767,15559,5890,20965,4414,3253,17316,17698,4402,4057,5632,12581
M10 [CHILD IMMUNIZATION],10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,9150,1566,763,78,131,874,1193,619,561,1194,270,1901
M10 [CHILD IMMUNIZATION],10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6338,1069,621,96,109,298,905,360,650,1006,208,1016
M10 [CHILD IMMUNIZATION],10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5937,1269,551,96,141,268,740,313,593,857,230,879
M10 [CHILD IMMUNIZATION],10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,164409,16000,11486,8373,16148,15410,20781,13454,10337,16878,12712,22830
M10 [CHILD IMMUNIZATION],10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8501,1065,578,369,512,1319,1494,650,489,710,479,836
M10 [CHILD IMMUNIZATION],10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3,0,0,0,3,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,84948,8160,5981,4416,8444,7833,10897,6689,5227,8310,6847,12144
M10 [CHILD IMMUNIZATION],10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,73447,7074,5183,3708,7285,7006,9508,5903,4574,7161,5685,10360
M10 [CHILD IMMUNIZATION],10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,158395,15234,11164,8124,15729,14839,20405,12592,9801,15471,12532,22504
M10 [CHILD IMMUNIZATION],10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,164890,15573,12011,8379,16130,15615,21343,13454,10410,15158,13500,23317
M10 [CHILD IMMUNIZATION],10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,163743,15538,11969,8374,16022,15516,20930,13295,10579,15057,13493,22970
M10 [CHILD IMMUNIZATION],10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,170320,16493,12422,8903,16593,13704,21547,15315,11174,17906,13619,22644
M10 [CHILD IMMUNIZATION],10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,24318,2408,791,1448,2678,2858,3398,2321,1235,866,1688,4627
M10 [CHILD IMMUNIZATION],10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,20613,2082,684,990,2215,2729,3025,1855,1110,762,1361,3800
M10 [CHILD IMMUNIZATION],10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,44931,4490,1475,2438,4893,5587,6423,4176,2345,1628,3049,8427
M10 [CHILD IMMUNIZATION],10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,79599,8646,5995,4389,6944,5866,9661,6149,5426,7761,7174,11588
M10 [CHILD IMMUNIZATION],10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,22785,2702,1919,1895,1518,1655,2524,1594,1920,2465,1889,2704
M10 [CHILD IMMUNIZATION],10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,14939,2438,1103,1225,1361,858,1673,1469,1057,1307,1358,1090
M10 [CHILD IMMUNIZATION],10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7,0,5,0,0,0,2,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,12,4,1,0,0,0,2,1,1,3,0,0
M10 [CHILD IMMUNIZATION],10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,63126,8243,4998,3521,6253,4502,8623,4112,3663,6290,4120,8801
M10 [CHILD IMMUNIZATION],10.4.2,Number of Immunisation sessions held during the month,TOTAL,61448,8083,4876,3307,6050,4437,8406,4014,3610,6119,3975,8571
M10 [CHILD IMMUNIZATION],10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,33489,1777,3174,1444,3559,3502,4204,1983,1901,3942,3140,4863
M10 [CHILD IMMUNIZATION],10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4,0,0,0,0,0,0,0,0,4,0,0
M11 [Number of Vitamin A doses],11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,112268,8665,11123,4037,8557,12345,11196,9263,8211,11348,12044,15479
M11 [Number of Vitamin A doses],11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,80177,5064,10207,1838,10388,7009,7780,6262,4866,8523,5584,12656
M11 [Number of Vitamin A doses],11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,33977,1704,4669,826,3741,3952,3643,2491,1898,4423,2147,4483
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,2,0,0,1,0,0,1,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,3,0,0,3,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,6,0,0,6,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,477,41,46,64,47,11,59,101,65,24,4,15
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,63473,4662,5752,6606,18892,1075,6366,3200,1966,3855,1948,9151
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,796,123,53,234,177,0,98,38,23,24,18,8
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,10650,1001,1024,3044,514,0,1082,439,1030,283,260,1973
M13 [Blindness Control Programme],13.1,Number of Patients operated for cataract,TOTAL,26488,12886,538,3556,424,212,2402,1058,338,1404,89,3581
M13 [Blindness Control Programme],13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,25044,12706,244,3517,238,212,2022,804,333,1344,58,3566
M13 [Blindness Control Programme],13.3,Number of School children detected with Refractive errors,TOTAL,12129,543,176,0,987,372,1660,1818,1317,450,534,4272
M13 [Blindness Control Programme],13.4,Number of children provided free glasses,TOTAL,1349,0,0,0,0,0,421,0,0,0,0,928
M13 [Blindness Control Programme],13.5,Number of eyes collected through eye donation,TOTAL,898,732,0,49,0,0,0,12,0,0,0,105
M13 [Blindness Control Programme],13.6,Number of eyes utilised for corneal transplant,TOTAL,541,409,0,24,0,0,0,3,0,0,0,105
M14 [Patient Services],14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,232,33,13,24,18,23,52,31,5,3,6,24
M14 [Patient Services],14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA
M14 [Patient Services],14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2233,34,28,0,0,0,1560,0,231,298,26,56
M14 [Patient Services],14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,202,24,22,6,18,24,36,30,NA,6,12,24
M14 [Patient Services],14.05,Number of RKS meetings held during the month,TOTAL,39,5,0,0,3,5,14,1,0,2,4,5
M14 [Patient Services],14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1063,85,211,161,31,23,128,66,55,66,159,78
M14 [Patient Services],14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,25699,1687,3196,7921,594,618,3020,1408,687,1307,1583,3678
M14 [Patient Services],14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,349,54,29,29,16,1,57,42,40,31,20,30
M14 [Patient Services],14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1026,187,89,193,13,0,306,34,29,80,17,78
M14 [Patient Services],14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,153976,28429,11834,38222,5215,1568,24642,14037,4503,8492,5523,11511
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,320359,95637,17057,40758,3811,2384,50919,33641,10363,22691,9677,33421
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,120146,16704,7632,38050,3961,1365,19548,10444,3493,5152,4661,9136
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,414813,86829,25478,55490,9984,6256,69567,54112,14178,25630,17003,50286
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,274122,45133,19466,76272,9176,2933,44190,24481,7996,13644,10184,20647
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,735172,182466,42535,96248,13795,8640,120486,87753,24541,48321,26680,83707
M14 [Patient Services],14.10.2.a,Number of death cases of Inpatient males,TOTAL,13212,4215,1105,3001,251,11,2037,641,236,275,114,1326
M14 [Patient Services],14.10.2.b,Number of death cases of Inpatient females,TOTAL,7875,2194,644,1775,96,19,1323,474,155,184,60,951
M14 [Patient Services],14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,21087,6409,1749,4776,347,30,3360,1115,391,459,174,2277
M14 [Patient Services],14.11,In-Patient Head Count at midnight,TOTAL,2553964,373741,178718,700474,77217,22254,345904,196450,103232,219631,65498,270845
M14 [Patient Services],14.12.1,OPD attendance (All),TOTAL,32932981,4584498,1933690,4952203,1975525,1483955,4497535,3432115,1468279,2070194,2200590,4334397
M14 [Patient Services],14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,170826,38886,11768,30298,1979,1246,23546,10593,10370,16679,3288,22173
M14 [Patient Services],14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,3873,742,339,538,151,22,791,235,280,290,230,255
M14 [Patient Services],14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,0,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,337678,23520,23428,49342,17714,7217,61793,14998,2780,11000,3817,122069
M14 [Patient Services],14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,0,0,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.14.a,Number of patients given AYUSH treatment,TOTAL,1033283,153464,120431,116215,97533,2107,97071,135399,23717,109091,48349,129906
M14 [Patient Services],14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,301060,75099,7136,76890,16403,1077,36730,9890,5523,15979,16671,39662
M14 [Patient Services],14.14.c,Number of Adolescents counselled,TOTAL,38692,8827,2600,2317,4350,2025,7794,1271,240,1541,4117,3610
M15 [Laboratory Testing],15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,1045393,1027016,NA,NA,NA,NA,NA,18377,NA,NA,NA,NA
M15 [Laboratory Testing],15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3325790,1168527,187533,396685,100173,51029,381668,262613,212154,101661,131302,332445
M15 [Laboratory Testing],15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,76923,12800,4162,8698,3095,1873,10157,11107,2388,1231,2978,18434
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,1. Number tested,159669,29050,15502,35345,5269,3968,21990,10649,15837,3563,4649,13847
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1731,201,84,522,54,72,356,125,91,22,42,162
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,99621,12834,7915,16601,4931,4272,16151,8656,9027,3381,4012,11841
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,663,50,51,224,13,9,137,35,29,9,15,91
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,147799,21639,9587,16048,13327,12111,23041,13266,7183,5196,12489,13912
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,577,28,11,30,10,135,81,215,17,2,8,40
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,407089,63523,33004,67994,23527,20351,61182,32571,32047,12140,21150,39600
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2971,279,146,776,77,216,574,375,137,33,65,293
M15 [Laboratory Testing],15.2,Number of Widal tests conducted,Number tested,201835,19546,13583,21297,15619,4504,32626,21200,9720,9560,15524,38656
M15 [Laboratory Testing],15.3.a,Number of VDRL tests conducted on males,Number tested,33471,2749,7906,10402,1364,201,1413,1559,3359,1252,680,2586
M15 [Laboratory Testing],15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,34169,2597,1779,10636,1885,1382,2827,977,1530,1145,1138,8273
M15 [Laboratory Testing],15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,140193,14540,8099,16846,9811,8780,27842,11775,6542,5930,14356,15672
M15 [Laboratory Testing],15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,207833,19886,17784,37884,13060,10363,32082,14311,11431,8327,16174,26531
M15 [Laboratory Testing],15.4.1,Number of blood smears examined for Malaria,TOTAL,451161,20857,13186,25373,6771,3816,39674,37482,232830,13137,20227,37808
M15 [Laboratory Testing],15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3067,103,255,279,65,37,478,401,618,307,178,346
M15 [Laboratory Testing],15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,665,6,18,12,0,3,366,3,15,238,3,1
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,231590,11410,16700,25040,21750,11850,25560,9110,31920,20210,26570,31470
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,2. Stocks Received,232690,31000,14500,9000,18520,15000,30630,17100,19440,22500,21500,33500
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,3. Unusable Stock,20960,2560,0,0,0,0,18400,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,4. Stock Distributed,229747,24680,17810,11800,13810,16417,31270,18230,21370,24120,22540,27700
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,5. Total Stock,213573,15170,13390,22240,26460,10433,6520,7980,29990,18590,25530,37270
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,268710,21750,9430,28700,12610,24910,22460,17290,37220,36540,28430,29370
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,2. Stocks Received,395730,43200,25560,23040,26160,37540,66720,35080,24670,40560,24000,49200
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,12870,490,0,0,0,0,12380,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,360120,38070,26850,21420,22620,27560,59430,34280,23410,35730,25140,45610
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,5. Total Stock,291450,26390,8140,30320,16150,34890,17370,18090,38480,41370,27290,32960
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,370210,52100,23020,31140,13730,18240,11920,17880,49120,43060,39400,70600
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,2. Stocks Received,646020,94100,47040,60780,28000,40000,73080,51000,49000,54000,34000,115020
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,3. Unusable Stock,11020,1760,0,0,0,0,9260,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,4. Stock Distributed,633150,101080,47040,63080,23690,26580,61300,54780,42340,46280,45820,121160
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,5. Total Stock,372060,43360,23020,28840,18040,31660,14440,14100,55780,50780,27580,64460
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,259304,39930,9740,33110,17070,12990,27450,15900,33610,24264,34710,10530
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,2. Stocks Received,353410,59500,16060,21000,21500,21490,66500,18000,22170,37500,37000,32690
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,3. Unusable Stock,12870,0,0,0,0,0,12870,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,4. Stock Distributed,307594,45600,17390,18660,18260,17070,56440,21479,16310,32555,29950,33880
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,5. Total Stock,292250,53830,8410,35450,20310,17410,24640,12421,39470,29209,41760,9340
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,1500,0,0,NA,1500,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,2. Stocks Received,3300,0,0,NA,3300,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,4. Stock Distributed,1980,0,0,NA,1980,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,5. Total Stock,2820,0,0,0,2820,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,217610,8690,11710,21930,15940,12810,28010,14040,47920,31770,11040,13750
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,2. Stocks Received,233110,25500,10000,37000,13500,14000,43500,20350,13260,17000,8000,31000
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,3. Unusable Stock,16790,1620,0,0,0,0,15170,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,4. Stock Distributed,221680,24530,11640,33790,12250,11590,39240,21530,12540,17790,9080,27700
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,5. Total Stock,212250,8040,10070,25140,17190,15220,17100,12860,48640,30980,9960,17050
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,207260,13875,10575,26070,11450,14480,17600,9865,34055,22315,23870,23105
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,2. Stocks Received,229510,25000,16190,10800,17500,17750,38000,16930,15840,25000,16000,30500
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,3. Unusable Stock,12500,1600,0,0,0,0,10900,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,4. Stock Distributed,205515,19700,15970,10595,16025,14820,36435,17825,13990,22630,13730,23795
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,5. Total Stock,218755,17575,10795,26275,12925,17410,8265,8970,35905,24685,26140,29810
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,103800,4470,12880,17710,5570,5070,12230,14130,6840,6390,8290,10220
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,103850,17210,1890,21000,4000,2000,21840,16230,2680,3000,3500,10500
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,7460,280,0,0,0,0,7180,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,97170,15170,4460,19280,2760,1600,15520,16460,3800,3680,3940,10500
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,103020,6230,10310,19430,6810,5470,11370,13900,5720,5710,7850,10220
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,35672,3950,2031,1309,6112,1284,2808,4380,2409,3980,5215,2194
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,20183,1800,1433,1400,3600,1150,2400,2600,1200,1200,1000,2400
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,1114,219,0,0,0,0,895,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,26155,1661,1361,868,1799,523,2062,11370,1307,1260,1435,2509
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,28586,3870,2103,1841,7913,1911,2251,-4390,2302,3920,4780,2085
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,2671340,42520,16960,191300,138980,83120,1911600,32720,167400,64800,21940,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,1605810,106560,38500,97200,139630,43200,689400,59820,238000,193500,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,983640,8640,0,0,0,0,975000,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,1476280,85060,33180,28380,123420,68950,663000,61620,200200,193500,18970,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,1817230,55380,22280,260120,155190,57370,963000,30920,205200,64800,2970,0
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,120688,6985,5251,8230,19300,9260,7457,9500,14100,16640,12965,11000
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,73121,7500,4471,4500,11200,3000,8000,6950,8000,8000,4500,7000
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,7013,3231,0,0,0,0,3782,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,61423,6939,3614,3300,6510,3370,7945,7050,6650,8010,3625,4410
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,125373,4315,6108,9430,23990,8890,3730,9400,15450,16630,13840,13590
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,49167,1276,4555,1875,8960,2420,13266,6300,1920,1365,4850,2380
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,12330,600,3225,600,1800,500,0,2000,1320,885,700,700
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,7171,61,0,0,0,0,7110,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,10092,501,1715,182,800,249,2222,2500,620,385,395,523
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,44234,1314,6065,2293,9960,2671,3934,5800,2620,1865,5155,2557
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1534,NA,0,0,0,0,664,120,250,0,300,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,2200,NA,0,1000,0,0,NA,300,300,0,400,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,664,NA,0,0,0,0,664,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,1700,NA,0,900,0,0,NA,300,200,0,100,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1370,0,0,100,0,0,0,120,350,0,600,200
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,2,NA,0,NA,0,2,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,-2,0,0,0,0,-2,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,779650,127300,0,97800,59100,37000,376350,52100,NA,NA,30000,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,2. Stocks Received,835000,90000,0,270000,240000,120000,10000,105000,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,30000,NA,0,0,0,0,30000,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,616700,141550,0,103950,131300,45500,81750,105000,NA,NA,7650,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,5. Total Stock,967950,75750,0,263850,167800,111500,274600,52100,0,0,22350,0
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,3000,NA,0,NA,0,3000,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,9500,NA,0,NA,0,9500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,3500,NA,0,NA,0,3500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,9000,0,0,0,0,9000,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,7783,NA,673,108,295,144,3873,436,721,437,1037,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,7008,NA,700,500,800,493,2160,605,550,700,500,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,148,NA,0,0,0,0,148,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,5158,NA,961,301,535,303,607,647,401,668,676,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,5. Total Stock,9485,0,412,307,560,334,5278,394,870,469,861,0
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,42870,NA,0,11950,6600,0,3600,14700,NA,NA,6020,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,87600,NA,0,11600,34200,0,41600,200,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,94360,NA,0,11100,32600,0,41400,5700,NA,NA,3560,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,36110,0,0,12450,8200,0,3800,9200,0,0,2460,0
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,210865,13130,13071,19795,10050,14104,32000,11950,46360,21100,15725,13580
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,173085,13000,12945,35000,16000,4000,29000,15250,11090,16000,4000,16800
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,19000,800,0,0,0,0,18200,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,152221,15320,9311,25490,14250,5650,24200,16350,5400,11900,6210,18140
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,212729,10010,16705,29305,11800,12454,18600,10850,52050,25200,13515,12240
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2198370,232800,22810,103300,425470,68600,156200,54600,429800,337000,125600,242190
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,1428000,146800,71900,46800,216000,93600,208600,90000,118500,139600,121800,174400
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,205000,101700,0,0,0,0,103300,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1263470,136400,75090,53400,124500,79100,211600,87400,80500,150700,101050,163730
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2157900,141500,19620,96700,516970,83100,49900,57200,467800,325900,146350,252860
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,274120,36760,11100,6550,13300,10480,35900,10700,55750,60600,17130,15850
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,109430,13000,12500,2000,7000,2000,18500,12400,10530,8000,8000,15500
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,31700,12600,0,0,0,0,19100,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,90810,7470,8620,2040,7950,2600,15100,8900,4900,10600,9755,12875
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,261040,29690,14980,6510,12350,9880,20200,14200,61380,58000,15375,18475
M17 [Details of deaths reported during the month with probable causes:],17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,86,18,1,8,4,6,45,1,1,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,307,42,128,95,3,NA,22,1,2,NA,3,11
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,80,7,26,29,5,NA,12,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,387,49,154,124,8,NA,34,1,2,NA,3,12
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,199,25,53,90,5,NA,20,2,3,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,8,NA,2,4,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,207,25,55,94,5,NA,21,2,3,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,316,41,4,94,4,3,29,NA,2,1,2,136
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,12,2,NA,4,NA,NA,5,1,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,328,43,4,98,4,3,34,1,2,1,2,136
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,389,25,69,108,6,8,96,3,1,6,7,60
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,34,2,12,5,2,3,10,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,423,27,81,113,8,11,106,3,1,6,7,60
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,119,7,31,60,5,NA,10,1,2,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,56,2,13,33,1,NA,4,2,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,175,9,44,93,6,NA,14,3,2,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,34,1,NA,21,1,1,7,1,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,13,NA,NA,11,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,47,1,NA,32,1,1,8,1,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,33,NA,NA,28,NA,2,1,NA,NA,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,35,NA,NA,31,1,NA,1,NA,1,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,68,NA,NA,59,1,2,2,NA,1,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,323,15,70,156,10,5,40,9,7,NA,3,8
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,132,7,26,56,4,2,14,4,2,NA,1,16
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,455,22,96,212,14,7,54,13,9,NA,4,24
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,6,NA,NA,5,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,92,24,2,44,1,NA,13,1,NA,NA,2,5
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,51,8,1,15,NA,NA,21,1,NA,NA,NA,5
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,149,32,3,64,1,NA,35,2,NA,NA,2,10
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,18,NA,NA,11,NA,NA,5,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,242,13,11,89,3,NA,73,8,1,1,NA,43
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,159,12,7,70,3,NA,33,5,NA,1,5,23
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,419,25,18,170,6,NA,111,13,1,2,5,68
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,51,2,4,38,2,NA,2,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,408,41,29,130,11,NA,99,12,2,6,8,70
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,665,94,79,110,21,NA,178,21,4,16,21,121
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1124,137,112,278,34,NA,279,33,6,22,29,194
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,1,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,10,NA,1,2,NA,NA,6,NA,1,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,12,NA,1,3,NA,NA,7,NA,1,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,56,1,NA,41,1,NA,10,1,NA,1,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,207,27,2,40,11,NA,83,NA,NA,1,2,41
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,121,24,1,13,4,NA,59,NA,NA,2,1,17
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,384,52,3,94,16,NA,152,1,NA,4,3,59
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,43,3,1,5,NA,NA,16,1,NA,NA,NA,17
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,5,NA,NA,2,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,48,3,1,7,NA,NA,19,1,NA,NA,NA,17
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,15,1,2,5,NA,NA,5,NA,1,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,564,53,40,179,21,NA,123,22,10,6,25,85
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1096,142,77,304,28,NA,199,31,48,22,39,206
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1675,196,119,488,49,NA,327,53,59,28,65,291
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,19,NA,NA,13,1,NA,5,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,219,25,12,29,5,NA,93,17,NA,NA,2,36
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,203,30,30,15,2,NA,87,8,1,NA,11,19
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,441,55,42,57,8,NA,185,25,1,NA,13,55
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,3,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,3,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,31,5,NA,18,NA,NA,5,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,31,5,NA,18,NA,NA,5,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,16,3,NA,5,NA,NA,5,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,16,3,NA,5,NA,NA,5,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,18,2,1,12,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,18,2,1,12,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,172,18,2,46,4,1,13,60,2,NA,1,25
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,172,18,2,46,4,1,13,60,2,NA,1,25
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,15,NA,2,11,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,496,15,40,241,61,NA,69,1,NA,NA,5,64
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,117,6,19,37,7,NA,21,1,1,NA,4,21
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,628,21,61,289,68,NA,91,2,1,NA,9,86
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,44,NA,NA,2,12,NA,17,1,NA,NA,10,2
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,8,1,2,1,1,NA,2,NA,NA,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,53,2,2,3,13,NA,19,1,NA,NA,11,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,8,NA,NA,1,2,NA,2,NA,NA,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,11,1,NA,1,3,NA,2,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,105,6,51,43,NA,NA,3,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1091,112,3,804,8,NA,90,4,NA,NA,2,68
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,752,153,3,483,2,NA,67,7,NA,NA,2,35
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1948,271,57,1330,10,NA,160,11,NA,NA,4,105
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,43,5,7,27,NA,NA,3,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,906,114,31,400,8,NA,186,19,NA,NA,7,141
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,898,160,49,282,9,NA,220,32,NA,1,22,123
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1847,279,87,709,17,NA,409,51,NA,1,29,265
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,17,NA,10,1,1,NA,NA,3,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,686,16,251,85,63,NA,147,61,2,4,8,49
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,467,7,141,41,7,NA,132,72,17,8,31,11
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1170,23,402,127,71,NA,279,136,19,12,39,62
